Aristea Kalikaki

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC

Aristea Kalikaki, Anastasios Koutsopoulos, Maria Trypaki et al. · British Journal of Cancer · 2008 · 207 citations · Full text

DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non–Small-Cell Lung Cancer

Aristea Kalikaki, Maria Kanaki, Helen Vassalou et al. · Clinical Lung Cancer · 2009 · 149 citations

Genome Instability, Oncology, Medicine +7

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients

Zacharenia Saridaki, Maria Tzardi, Chara Papadaki et al. · PLoS ONE · 2011 · 124 citations · Full text

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status

Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki et al. · Lung Cancer · 2009 · 88 citations

Medicine, Pathology, K-ras Mutation Status +7

Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer

Alexandra Voutsina, Maria Tzardi, Aristea Kalikaki et al. · Modern Pathology · 2012 · 53 citations · Full text

Oncology, Medicine, Pten Expression +8